The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease.
Nils D. Arvold
No relevant relationships to disclose
Ming-Hui Chen
No relevant relationships to disclose
Judd W. Moul
No relevant relationships to disclose
Brian Joseph Moran
No relevant relationships to disclose
Daniel E. Dosoretz
No relevant relationships to disclose
Lionel Lloyds Banez
No relevant relationships to disclose
Michael J. Katin
No relevant relationships to disclose
Michelle H. Braccioforte
No relevant relationships to disclose
Anthony V. D'Amico
No relevant relationships to disclose